5-(1,3-benzodioxol-5-yl)-3-pyridin-4-yl-1,2,4-oxadiazole;4-[5-(4-cyclohexylphenyl)-1,2,4-oxadiazol-3-yl]benzenesulfonamide;5-(3,4-diethoxyphenyl)-3-pyridin-2-yl-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-pyridin-3-yl-1,2,4-oxadiazole;4-[5-[4-phenyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-3-yl]benzenesulfonamide
C89H78F3N15O15S2 — CID 161232664
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-(1,3-benzodioxol-5-yl)-3-pyridin-4-yl-1,2,4-oxadiazole;4-[5-(4-cyclohexylphenyl)-1,2,4-oxadiazol-3-yl]benzenesulfonamide;5-(3,4-diethoxyphenyl)-3-pyridin-2-yl-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-pyridin-3-yl-1,2,4-oxadiazole;4-[5-[4-phenyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-3-yl]benzenesulfonamide
5-(1,3-benzodioxol-5-yl)-3-pyridin-4-yl-1,2,4-oxadiazole;4-[5-(4-cyclohexylphenyl)-1,2,4-oxadiazol-3-yl]benzenesulfonamide;5-(3,4-diethoxyphenyl)-3-pyridin-2-yl-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-pyridin-3-yl-1,2,4-oxadiazole;4-[5-[4-phenyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-3-yl]benzenesulfonamide (PubChem CID 161232664) has the molecular formula C89H78F3N15O15S2 and a molecular weight of 1718.82 g/mol. Its IUPAC name is 5-(1,3-benzodioxol-5-yl)-3-pyridin-4-yl-1,2,4-oxadiazole;4-[5-(4-cyclohexylphenyl)-1,2,4-oxadiazol-3-yl]benzenesulfonamide;5-(3,4-diethoxyphenyl)-3-pyridin-2-yl-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-pyridin-3-yl-1,2,4-oxadiazole;4-[5-[4-phenyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-3-yl]benzenesulfonamide.
Molecular Properties
| Compound Name | 5-(1,3-benzodioxol-5-yl)-3-pyridin-4-yl-1,2,4-oxadiazole;4-[5-(4-cyclohexylphenyl)-1,2,4-oxadiazol-3-yl]benzenesulfonamide;5-(3,4-diethoxyphenyl)-3-pyridin-2-yl-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-pyridin-3-yl-1,2,4-oxadiazole;4-[5-[4-phenyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-3-yl]benzenesulfonamide |
|---|---|
| PubChem CID | 161232664 |
| Molecular Formula | C89H78F3N15O15S2 |
| Molecular Weight | 1718.82 g/mol |
| Exact Mass | 1717.52 |
| IUPAC Name | 5-(1,3-benzodioxol-5-yl)-3-pyridin-4-yl-1,2,4-oxadiazole;4-[5-(4-cyclohexylphenyl)-1,2,4-oxadiazol-3-yl]benzenesulfonamide;5-(3,4-diethoxyphenyl)-3-pyridin-2-yl-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-pyridin-3-yl-1,2,4-oxadiazole;4-[5-[4-phenyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-3-yl]benzenesulfonamide |
| SMILES | CCOc1ccc(-c2nc(-c3ccccn3)no2)cc1OCC.CCOc1ccc(-c2nc(-c3cccnc3)no2)cc1OCC.NS(=O)(=O)c1ccc(-c2noc(-c3ccc(-c4ccccc4)c(C(F)(F)F)c3)n2)cc1.NS(=O)(=O)c1ccc(-c2noc(-c3ccc(C4CCCCC4)cc3)n2)cc1.c1cc(-c2noc(-c3ccc4c(c3)OCO4)n2)ccn1 |
| InChI | InChI=1S/C21H14F3N3O3S.C20H21N3O3S.2C17H17N3O3.C14H9N3O3/c22-21(23,24)18-12-15(8-11-17(18)13-4-2-1-3-5-13)20-26-19(27-30-20)14-6-9-16(10-7-14)31(25,28)29;21-27(24,25)18-12-10-16(11-13-18)19-22-20(26-23-19)17-8-6-15(7-9-17)14-4-2-1-3-5-14;1-3-21-14-8-7-12(10-15(14)22-4-2)17-19-16(20-23-17)13-6-5-9-18-11-13;1-3-21-14-9-8-12(11-15(14)22-4-2)17-19-16(20-23-17)13-7-5-6-10-18-13;1-2-11-12(19-8-18-11)7-10(1)14-16-13(17-20-14)9-3-5-15-6-4-9/h1-12H,(H2,25,28,29);6-14H,1-5H2,(H2,21,24,25);2*5-11H,3-4H2,1-2H3;1-7H,8H2 |
| InChIKey | UYYPDYINIPMBCG-UHFFFAOYSA-N |
| XLogP | 18.55 |
| TPSA | 408.97 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 28 |
| Rotatable Bonds | 22 |
| Heavy Atoms | 124 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1718.82 |
| LogP ≤ 5 | 18.55 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 28 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 161232664 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.